Considering the Future of Pharmaceutical Promotions in Social Media: Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"

This commentary explores the implications of increased social media marketing by drug manufacturers, based on findings in Hyosun Kim’s article of the major themes in recent Food and Drug Administration (FDA) warning letters and notices of violation regarding online direct-to-consumer promotions of p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Health Policy Manag
Autor principal: Carpentier, Francesca Renee Dillman
Format: Artigo
Idioma:Inglês
Publicat: Kerman University of Medical Sciences 2016
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818997/
https://ncbi.nlm.nih.gov/pubmed/27239874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15171/ijhpm.2016.15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars